法律办公室
法律办公室Richard Aron Osman
法学博士，哲学博士
北京生命科学研究所首席法律顾问电话： 86-10-80726688传真： 86-10-80726689mail: richard@nibs.ac.cn
教育经历
Education
1992年 美国加利福尼亚大学 法学博士
Ph.D. in Judicial Science, University of California, USA
1988年 美国加利福尼亚大学 分子细胞生物学博士
Ph.D. in Molecular Cell Biology University of California, USA
1984年 美国加利福尼亚大学 动物学学士
B.S. in Zoology, University of California, USA
工作经历
Professional Experience
2012年 - 北京生命科学研究所首席法律顾问
General Counsel, NIBS, Beijing, China, National Institute of Biological Sciences, Beijing, China
1995年 - 美国科学与技术法律集团, 专利代理
Patent Attorney, Science & Technology Law Group, USA
1990 - 1995年 美国 Flehr, Hohbach, Test, Albritton & Herbert, LLC公司，专利代理
Patent Attorney, USA Flehr, Hohbach, Test, Albritton & Herbert, LLC
部门介绍
Department Introduction
法律部的使命是，为NIBS提供适合的方案、运作和管理方面的服务，包括周到、实用和创造性的建议、咨询和其他有关法律、政策和运作事宜的服务，以达到推动NIBS的方案和运作的目的。法律部有责任确保NIBS获得必要的法律咨询和指导，以保证NIBS的合约安排符合其活动和目标，并保护NIBS免受不必要的法律及其他风险。
我们的职责包括为NIBS及其科学家提供知识产权需求方面的服务，包括获得，管理和许可专利，并促进NIBS和外部的科学家及研究机构之间的研究合作和协议。
The mission of the Legal Department is to advance the programs and operations of NIBS by providing thoughtful, practical, and creative advice, counsel, and other services on legal, policy, and operational matters applicable to NIBS’ programs, operations, and governance. The Legal Department has responsibility for assuring that NIBS receives the legal advice and guidance necessary to assure that its contractual arrangements are appropriate in light of the organization’s activities and objectives and to protect the organization from undue legal and other risk.
Our responsibilities include servicing the intellectual property needs of NIBS and our scientists, including procuring, managing and licensing patents, and facilitating research collaborations and agreements between NIBS and outside scientists and institutions.
职业成就
Professional Accomplishments
-All aspects of patent prosecution, US and International
>500 US patents drafted, filed, prosecuted and issued
>1,000 world-wide patents drafted, filed, prosecuted, issued
>100 appeals before Board of Patent Appeals & Interferences
- Appeals before US Court of Appeals, Federal Circuit
- Interferences before Board of Patent Appeals & Interferences
- Inter Partes and Ex Parte Reexaminations
- Expert opinions re infringement, validity, patentability, FTO
- Contract, negotiations re licensing, ownership, research agreements
联邦巡回法院裁决
Federal Circuit Decisions
In re Berg, 320 F.3d. 1310 (Fed Cir 2003)
In re Ngai, 367 F.3d 1336 (Fed Cir 2004)
专利上诉与冲突委员会裁决
BPAI Decisions
Ex parte Jay D. Keasling et al., No. 1997-2755; Ex parte George Chang et al., No. 1997-1770; Ex parte Berg et al., No. 1999-2231; Ex parte Takeshi Sano et al, No. 2000-0630; Ex parte Shervin K. Pishevar, No. 2000-1919; Ex parte Fabienne Charleles De La Brousse et al., No. 2001-1148; Ex Parte Bei Shan et al, No. 2000-0441; Ex parte Gerald M Rubin et al., No. 2004-1106; Ex parte Daniel Tim Curtis et al., No. 2006-1897; Ex parte Steven E. Brenner et al., No. 2006-1569; Ex Parte Joachim Herz et al., No. 2006-2556; Ex parte Richard Harland et al., No. 2007-0079; Ex parte Kevin H. Gardner et al., No. 2007-2956; Ex parte Brett P. Giroir et al., No. 2007-4508; Ex parte Haiying Xia et al., No. 2008-3329; Ex parte Zhigang He et al., No. 2008-6199; Ex parte Wendell Lim et al., No. 2008-3676; Ex parte Duojia Pan et al., No. 2008-6237; Ex parte Deepak Srivastava et al., No. 2008-6034; Ex parte Zhigang He, No. 2008-002333; Ex parte Kevin H. Gardner et al., No. 2009, 009581; Ex parte Srivastava et al., No. 2009-011225; Ex parte Heng Wei Chang, No. 2009-004009; Ex parte Paul R. Selvin et al., No. 2009-013065; Ex parte Richard A. Berg, No. 2010-001516; Ex parte Michael Kyba et al., No. 2010-009979; Ex parte Hani Atamna et al., No. 2011-006151
代表客户
Representative Clients
University of California, Stanford University, Harvard University, University of Texas, University of Illinois, USDA, Children’s Hospital Boston, Children’s Hospital Oakland, SRI International, Amgen, Angiotech, Affymetrix, Exelixis, Incyte, Joyant Pharmaceuticals, Svaya Nanotechnologies
代表专利
Representative Patents
US8172967, US7238659, US7282621, US6399024, US5993457, US7776816, US8013015, US7884211, US7829278, US7065451
